Glycopeptide Nanofiber Platform for Aβ-Sialic Acid Interaction Analysis and Highly Sensitive Detection of Aβ
- PMID: 31247730
- DOI: 10.1021/acs.analchem.9b00377
Glycopeptide Nanofiber Platform for Aβ-Sialic Acid Interaction Analysis and Highly Sensitive Detection of Aβ
Abstract
The variation of amyloid β peptide (Aβ) concentration and Aβ aggregation are closely associated with the etiology of Alzheimer's diseases (AD). The interaction of Aβ with the monosialoganglioside-rich neuronal cell membrane has been suggested to influence Aβ aggregation. Therefore, studies on the mechanism of Aβ and sialic acids (SA) interaction would greatly contribute to better understanding the pathogenesis of AD. Herein, we report a novel approach for Aβ-SA interaction analysis and highly sensitive Aβ detection by mimicing the cell surface presentation of SA clusters through engineering of SA-modified peptide nanofiber (SANF). The SANF displayed well-ordered 1D nanostructure with high density of SA on surface. Using FAM-labeled Aβ fragments of Aβ1-16, Aβ16-23, and Aβ24-40, the interaction between Aβ and SA was evaluated by the fluorescence titration experiments. It was found that the order of the SA-binding affinity was Aβ1-16 > Aβ24-40 > Aβ16-23. Importantly, the presence of full-length Aβ1-40 monomer triggered a significant fluorescence enhancement due to the multivalent binding of Aβ1-40 to the nanofiber. This fluorescent turn-on response showed high selectivity and sensitivity for Aβ1-40 detection and the method was further used for Aβ aggregation process monitoring and inhibitor screening. The results suggest the proposed strategy is promising to serve as a tool for mechanism study and the early diagnosis of Alzheimer's disease.
Similar articles
-
Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.Acta Biomater. 2015 Oct;25:172-83. doi: 10.1016/j.actbio.2015.06.035. Epub 2015 Jul 2. Acta Biomater. 2015. PMID: 26143603
-
Synthetic standard aided quantification and structural characterization of amyloid-beta glycopeptides enriched from cerebrospinal fluid of Alzheimer's disease patients.Sci Rep. 2019 Apr 2;9(1):5522. doi: 10.1038/s41598-019-41897-5. Sci Rep. 2019. PMID: 30940835 Free PMC article.
-
Abeta20-29 peptide blocking apoE/Abeta interaction reduces full-length Abeta42/40 fibril formation and cytotoxicity in vitro.Neuropeptides. 2010 Aug;44(4):305-13. doi: 10.1016/j.npep.2010.03.001. Epub 2010 Apr 2. Neuropeptides. 2010. PMID: 20363024
-
Detection of Amyloid-beta aggregates in body fluids: a suitable method for early diagnosis of Alzheimer's disease?Curr Alzheimer Res. 2009 Jun;6(3):285-9. doi: 10.2174/156720509788486536. Curr Alzheimer Res. 2009. PMID: 19519310 Review.
-
Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease.Biochim Biophys Acta. 2000 Jul 26;1502(1):172-87. doi: 10.1016/s0925-4439(00)00043-0. Biochim Biophys Acta. 2000. PMID: 10899442 Review.
Cited by
-
Self-assembled, hemin-functionalized peptide nanotubes: an innovative strategy for detecting glutathione and glucose molecules with peroxidase-like activity.Nano Converg. 2023 Feb 4;10(1):7. doi: 10.1186/s40580-023-00356-8. Nano Converg. 2023. PMID: 36738341 Free PMC article.
-
Recent Advances in the Application Peptide and Peptoid in Diagnosis Biomarkers of Alzheimer's Disease in Blood.Front Mol Neurosci. 2021 Dec 23;14:778955. doi: 10.3389/fnmol.2021.778955. eCollection 2021. Front Mol Neurosci. 2021. PMID: 35002620 Free PMC article. Review.
-
Organelle-Partitioned Sugar-Rhodamine Diad for In Vivo Tumor Imaging.ACS Omega. 2020 Jul 23;5(30):19014-19019. doi: 10.1021/acsomega.0c02323. eCollection 2020 Aug 4. ACS Omega. 2020. PMID: 32775903 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
